Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update ...Middle East

First patient dosed in randomized, Phase 2 study in presurgical triple negative breast cancer SHELTON, Conn., Nov. 13, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...

Read More Details
Finally We wish PressBee provided you with enough information of ( Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update )

Also on site :

• Mounting casualties: Russia and Ukraine exchange fire amid prisoner swap
• NYT Connections Sports Edition Today: Hints and Answers for May 25
• Cannes film festival impacted after major power cut hits southern France